Chapter 893
Drug Abuse Prevention and Control

Sections

893.035
Control of new substances; findings of fact; delegation of authority to Attorney General to control substances by rule
893.055
Prescription drug monitoring program
893.065
Counterfeit-resistant prescription blanks for controlled substances listed in Schedule II, Schedule III, Schedule IV, or Schedule V
893.101
Legislative findings and intent
893.105
Testing and destruction of seized substances
893.131
Distribution of controlled substances resulting in overdose or serious bodily injury
893.132
Dangerous fentanyl exposure of first responder resulting in overdose or serious bodily injury
893.135
Trafficking; mandatory sentences; suspension or reduction of sentences; conspiracy to engage in trafficking
893.138
Local administrative action to abate certain activities declared public nuisances
893.145
“Drug paraphernalia” defined
893.146
Determination of paraphernalia
893.147
Use, possession, manufacture, delivery, transportation, advertisement, or retail sale of drug paraphernalia, specified machines, and materials
893.149
Unlawful possession of listed chemical
893.165
County alcohol and other drug abuse treatment or education trust funds
893.0301
Death resulting from apparent drug overdose; reporting requirements
893.0355
Control of scheduled substances; delegation of authority to Attorney General to reschedule substance, or delete substance, by rule
893.0356
Control of new substances; findings of fact; “controlled substance analog” defined
893.0551
Public records exemption for the prescription drug monitoring program
893.1351
Ownership, lease, rental, or possession for trafficking in or manufacturing a controlled substance
893.1495
Retail sale of ephedrine and related compounds

Current through Fall 2025

Chap. 893. Drug Abuse Prevention & Control's source at flsenate​.gov